LifeMD (LFMD) Stock Forecast & Price Target

LifeMD Inc. has demonstrated significant growth in its Telehealth segment, with a 14% year-over-year increase in active subscribers, reaching 310,818 by the end of the third quarter. Total revenue saw a 12.7% increase to $60.2 million, with Telehealth revenue alone growing by 17.4% to $47.3 million, indicating a robust demand for its virtual healthcare services. Furthermore, the gross margin expanded to 87%, highlighting a favorable revenue mix that positions LifeMD for continued success in the evolving healthcare landscape.

LifeMD Inc is facing several fundamental challenges that contribute to a negative outlook on its stock. The revenue growth of $60.2 million, which represents a 13% year-over-year increase, fell short of the expected figures while the adjusted EBITDA of $5.1 million was also below projections, highlighting the company's struggles in achieving profitability. Furthermore, the reduction in full-year 2025 revenue guidance for telehealth to $192 million—coupled with risks such as increased competition, difficulties in patient acquisition, and potential dilution—raises concerns about the company's growth trajectory and ability to sustain its market position.